Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival. by Chien-Yu Huang (802982)

rhMG53 decreases membrane damage <i>in vitro</i>. by Brian J. Paleo (8694246)

Trial profile. by Chanel Avenant (409756)

Subjects:

Decreased expression of TCA cycle and ETC enzymes in kidneys from rats administered Tl. by Sho Sugahara (11895828)

Subjects:

Respective increase and decrease in Myc and NRF1/TFAM in kidneys from rats administered Tl. by Sho Sugahara (11895828)

Subjects:

An increase in MOI decreases neuronal dendrite numbers. by Emily Z. Tabaie (16630841)

Decreased type I IFN response in B cells carrying the MS-protective class I alleles. by Christian Lundtoft (4068679)

Relationship between decreased fluoride concentration and increased SO₄^2- concentration in solution at different proportions of metaettringite. by Atsushi Iizuka (3184404)

Subjects:

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Analgesic effect of morphine (4 mg/kg) was decreased after consecutive daily injections in NAMT. by Ghazaleh Ghamkharinejad (11414825)

DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”

<i>Ep300</i> siRNA suppressed osteoblast differentiation and decreased histone lactylation levels. by Erika Minami (17583343)

Testis tissue apoptosis post PM2.5 exposure. by Cao Wang (1500691)

Subjects:

Alterations in the post-PM2.5 exposure sperm quality ( ±s). by Cao Wang (1500691)

Subjects:

Combination treatment induced more cell death and decreased cell survival markers more than did single treatments. by Panchanan Maiti (1459852)

Weight-corrected CL/F, showing decrease with age (filled circles: individual estimates for weight-corrected CL/F; lines: median and CI5% and CI95% for CL/F). by Jaime Altcheh (373341)

Losartan increased ACE-2 expression, while SARS-CoV-2 spike protein decreased ACE-2 expression in hACE2 brains. by Mackenzi Meier (19251139)

“…<p>hACE2 KI mice were treated only with Losartan or intravenously injected with SARS-CoV-2 spike protein (SP, 4 μg/ animal) with or without Losartan (10 mg/kg body weight) for 2 weeks. …”

Decrease of muscle weakness and degeneration with mutants of UPS components. by Cécile Ribot (11944875)

Post-losartan treatment prevented SARS-CoV-2 spike protein-induced decreased cognitive impairment but not pre-losartan treatment. by Mackenzi Meier (19251139)